Group leader, Brain-C Lab
Inserm Avenir, APHP DHU
- https://elifesciences.org/articles/64984
- https://onlinelibrary.wiley.com/doi/full/10.1111/acel.13226
- Bigan E, Nair SS, Lejeune FX, Fragnaud H, Parmentier F, Megret L, Verny M, Aaronson J, Rosinski J, and Néri C. Genetic cooperativity in multi-layer networks implicates cell survival and senescence in the striatum of Huntington's disease mice synchronous to symptoms. Bioinformatics2019, doi: 10.1093/bioinformatics/btz514.2.
- Kacher R, Lamazière A, Heck N, Kappes V, Mounier C, Despres G, Dembitskaya Y, Perrin E, Christaller W, Sasidharan Nair S, Messent V, Cartier N, Vanhoutte P, Venance L, Saudou F, Néri C, Caboche J, Betuing S.CYP46A1 gene therapy deciphers the role of brain cholesterol metabolism in Huntington's disease. Brain 2019142, 2432-2450. doi: 10.1093/brain/awz1743.
- Vergallo, A., Megret, L., Lista, S., Cavedo, E., Zetterberg, H., Blennow, K., Vanmechelen, E., De Vos, A., Habert, M.O., Potier, M.C., Dubois B, Neri C, Hampel H. Plasma amyloid beta 40/42 ratio predicts cerebral amyloidosis in cognitively normal individuals at risk for Alzheimer's disease. Alzheimers Dement 2019, 15, 764-775.
MIT, UCLA, Buck Institute for Research on Aging, Baylor's College of Medicine
Ariana Pharma, BioMérieux,Biophytis,Bio-Rad, Gene-IT, GSK, Oxyproteomics, Novartis, Roche, Sanofi, Trophos